Sunday, May 16News That Matters

Tag: licensing

MSD to signal licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19

Drug firm MSD has made up our minds to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'molnupiravir', which is being studied for the medication of COVID-19, with Indian drug firms Solar Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm acknowledged on Tuesday. Molnupiravir is an investigational oral antiviral agent, at this time being studied in a Phase 3 trial for the medication of non-hospitalised patients with confirmed COVID-19, MSD India acknowledged in an announcement. MSD India is a completely owned subsidiary of Merck Consuming & Dohme (MSD) and identified as Merck & Co., Inc, in the US and Canada. MSD has made up our minds to enter into non-outlandish voluntary licensing agreements for molnupiravir with five ...